Aiforia Technologies has established a subsidiary in France to strengthen its local presence and to support its growing business in the country.
The firm has had a sales organisation in France since 2023, and interest in the Aiforia’s AI-based pathology solutions has grown significantly.
France is investing heavily in the use of artificial intelligence, with healthcare being one of the key priority areas where it aims to lead industry innovations. Since 2018, the state has invested more than €2.5 billion in research, education, and accelerating the adoption of AI as part of France's national artificial intelligence strategy. In addition, in February 2025 at the AI Action Summit in Paris, an €109 billion project was announced to invest in the country's artificial intelligence system, including data centres.
Aiforia already has a strong foothold in France; the first successful and significant collaboration with one of the world's leading hospitals, the AP-HP hospital group in Paris in 2024, was an important strategic market opening for Aiforia. Recently, Nantes University Hospital, France's sixth-largest hospital, also chose the company as its partner for AI-assisted pathology diagnostics.
The new subsidiary will support Aiforia's growth and customer service in France and enable even closer cooperation with local healthcare providers.
Jukka Tapaninen, CEO of Aiforia commented: “We strongly believe that we have a significant opportunity to offer innovative solutions to the French healthcare system that improve the accuracy and efficiency of pathology image analysis and support the development of our customers' diagnostic processes. We are confident that having a local presence is essential to offer our customers the best possible service."